國家中醫藥管理局:謀劃好中醫藥「十四五」規劃
國家中醫藥管理局近日召開2020年局長(擴大)會議,梳理總結今年以來的重點工作進展,分析面臨的新形勢、新機遇,針對存在的困難和問題,研究部署下一步重點任務要積極統籌推動貫徹落實各項重點工作,推動中醫藥傳承創新發展的相關配套文件出台,持續優化中醫藥事業發展的政策環境。
會議強調,要進一步深刻認識當前中醫藥發展的大好形勢,把握機遇,堅定中醫藥傳承創新發展的信心和決心,推動中央各部門及各地黨委政府進一步貫徹落實《中共中央國務院關於促進中醫藥傳承創新發展的意見》和全國中醫藥大會精神,結合各部門各地工作實際,出台系列政策舉措,營造中醫藥發展的良好外部環境。
下一步工作重點包括:要加強模範機關建設,以黨建促業務;切實推動中醫藥在常態化疫情防控中發揮更大作用,切實提高中醫藥應急和救治能力特別是疫病防治能力;做好中醫藥「十三五」規劃總結,結合新形勢新任務,著力破解制約中醫藥發展的瓶頸,謀劃好中醫藥「十四五」規劃;深化醫改中醫藥工作,進一步提升中醫藥服務能力;加大中醫藥扶貧力度,切實降低疫情對脫貧攻堅的影響等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.